Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorSwiss Federal Institute of Technology

About this trial

Serum ferritin is a key indicator of body iron stores and is widely used in monitoring iron status. However, oral iron doses can acutely elevate SF levels, potentially biasing assessments of iron stores during supplementation. This study aims to investigate the extent and duration of the acute iron-induced effect on serum ferritin following the administration of a daily iron dose for two months.

Eligibility criteria

Qualifiers

Low iron stores (SF levels < 30 µg/L),

no anemia (Hb > 120 g/L)

no inflammation (CRP < 5 mg/L)

18 to 45 years old.

Disqualifiers

Any chronic or acute disease

Consumption of mineral and vitamin supplements since screening and over the study period

Blood transfusion, blood donation or significant blood loss over the past 4 months,

Pregnant or breastfeeding,

Trial design

Treatments tested in this trial

  • ferrous sulfate 80 mg
  • ferrous sulfate 160 mg

Treatment groups

120 Participants
are divided into 2 treatment groups